The variability of ecstasy tablets composition in Brazil.
Loraine R Togni, Rafael Lanaro, Rodrigo R Resende, Jose L Costa
Journal of Forensic Sciences 2015 DOI: 10.1111/1556-4029.12584 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Sample size | 150 |
| Population | Seized ecstasy tablets from São Paulo State Police |
| Topics | MDMA |
| Keywords | Chemical profiling Designer drugs Forensic science Gas chromatography-mass spectrometry Forensic drug analysis Ecstasy composition Illicit drug markets |
| Citations | 54 |
| Key findings | MDMA was present in only 44.7% of seized ecstasy tablets, with 20 other active substances identified, indicating a shift away from MDMA in the illicit market. |
Abstract
The content of ecstasy tablets has been changing over the years, and nowadays 3,4-methylenedioxymethamphetamine (MDMA) is not always present in the tablets. The aim of this study was to investigate the chemical composition in the seized tablets labeled as ecstasy. We analyzed samples from 150 different seizures made by Sao Paulo's State Police by gas chromatography-mass spectrometry. MDMA was present in 44.7% of the analyzed samples, and another twenty different active substances were identified in these tablets, such as caffeine, 2C-B, piperazines, amphetamines, phencyclidine, and others. Methamphetamine was present in 22% of these samples. The results demonstrate a huge shift in the pattern of trafficking of synthetic drugs, where MDMA has been replaced in tablets mostly by illicit psychoactive substances, in a clear attempt to bypass the law. The great variability in the tablets composition may lead to an increased risk of drug poisoning.
Comparable studies
Other observational and cohort studies on MDMA, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Subjective Reports of the Effects of MDMA in a Clinical Setting Individuals who took MDMA in a clinical setting | 1986 | Observational study | |
| Memory impairment in abstinent MDMA ("Ecstasy") users Abstinent MDMA users | 1998 | Observational cohort | |
| Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) Otherwise healthy young people | 2000 | Observational | |
| The Psychological and Physiological Effects of MDMA on Normal Volunteers Older, more educated, drug-experienced individuals | 1986 | Observational cohort | |
| Cognitive performance in recreational users of MDMA or 'ecstasy': evidence for memory deficits Young people who were regular or novice MDMA users, or non-users | 1998 | Observational cohort | n = 30 |
Citations in the library
Cited by 11
- Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development Frontiers in Pharmacology July 5, 2018
- Who is ‘Molly’? MDMA adulterants by product name and the impact of harm-reduction services at raves Journal of Psychopharmacology July 10, 2017
- Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review Psychopharmacology March 7, 2022
- Neuroimaging of chronic MDMA (“ecstasy”) effects: A meta-analysis Neuroscience & Biobehavioral Reviews November 12, 2018
- Acute Effects of the Novel Psychoactive Drug 2C-B on Emotions BioMed Research International 2015
and 6 more in the library
Cites 3
- Instability of the ecstasy market and a new kid on the block: mephedrone Journal of Psychopharmacology September 8, 2010
- The content of ecstasy tablets: implications for the study of their long‐term effects Addiction December 1, 2002
- mCPP: an undesired addition to the ecstasy market. Journal of Psychopharmacology September 2010